National Immunization Technical Advisory Group

NFID Celebrates 50th Anniversary with Gala Honoring Public Health Heroes

Retrieved on: 
Wednesday, August 23, 2023
Vaccine, National Foundation for Infectious Diseases, CAE, PE, Vaccine-preventable diseases, Doctor of Pharmacy, Education, Medical college, COVID-19, Infection, Hepatitis B, Human, Research, History, Doctor of Philosophy, Respiratory syncytial virus, Bangladesh Technical Education Board, MS, CDC, Organization, CPNP, Pharmacist, RSV, National Immunization Technical Advisory Group, Nursing, Korea Disease Control and Prevention Agency, Cystic fibrosis, Schaffner, Duma, RN, MPH, Immunization, Conference, News, NFID, Pharmaceutical industry, MD

BETHESDA, Md., Aug. 23, 2023 /PRNewswire/ -- Today marks the 50th anniversary of the establishment of the National Foundation for Infectious Diseases (NFID) which will be commemorated with an elegant 50th Anniversary Gala in Washington, DC on September 14, 2023.

Key Points: 
  • BETHESDA, Md., Aug. 23, 2023 /PRNewswire/ -- Today marks the 50th anniversary of the establishment of the National Foundation for Infectious Diseases (NFID) which will be commemorated with an elegant 50th Anniversary Gala in Washington, DC on September 14, 2023.
  • Celebrating 50 years of education, prevention, and impact, the gala will recognize the work of NFID and the inspirational public health heroes who have helped protect the lives of millions.
  • NFID supporters and public health luminaries will gather in Washington, DC to celebrate the remarkable history and notable accomplishments at the NFID 50th Anniversary Gala on September 14, 2023.
  • An NFID 50th Anniversary Commemorative Book that looks back at the history of NFID and celebrates the trailblazing efforts of NFID leaders and public health heroes over the past 5 decades is also available for purchase online.

Wolters Kluwer survey shows U.S. pharmacies face headwinds on children’s vaccinations

Retrieved on: 
Wednesday, August 16, 2023
Retail, Generation Z, Generation X, Practice Management, Pharmaceutical, General Health, Baby Boomers, Infectious Diseases, Discount, Variety, Parenting, Other Retail, Department Stores, Supermarket, Family, Consumer, Health, Vaccine, Learning, BCPS, Baby boomers, Pharmacy, Doctor of Pharmacy, Vaccination, Parent, Wolters Kluwer, Research, COVID, Millennials, Shingles, Wolters, NIAM, Student, Trust, National Immunization Technical Advisory Group, Patient, Child, Adolescence, Immunization, Pediatrics, Pharmacist, Grocery store

That’s according to the results of the Pharmacy Next survey , commissioned by Wolters Kluwer Health , which found overall shifts away from primary care physicians for immunizations.

Key Points: 
  • That’s according to the results of the Pharmacy Next survey , commissioned by Wolters Kluwer Health , which found overall shifts away from primary care physicians for immunizations.
  • One area, childhood vaccinations, bucks that trend, posing headwinds for pharmacies seeking to grow adoption of their immunization services.
  • Contrasting the broader preference for getting adult vaccinations at pharmacies (62%), only 36% would choose a local pharmacy for children’s vaccines.
  • The division of Wolters Kluwer supports clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions.

Protecting against a "tripledemic": Vaccinating for the flu, RSV, and COVID-19

Retrieved on: 
Thursday, August 17, 2023
CDC, COVID-19, Pharmacist, RSV, Siesta Key (TV series), Interview, American Pharmacists Association, National Immunization Technical Advisory Group, Vaccination, Respiratory syncytial virus, Vaccine, Pharmaceutical industry

Pharmacists are available to discuss the following:

Key Points: 
  • Pharmacists are available to discuss the following:
    The most current recommendations for the RSV vaccine, such as who should get it and when
    These interviews can be conducted live or recorded for future publication and broadcast.
  • Weekly hospital admissions for COVID-19 are rising for the first time since last winter.
  • Public health experts are concerned about the possibility that Americans may be vulnerable to a " tripledemic " of the flu, RSV, and COVID-19 this fall and winter.
  • APhA also observes National Immunization Awareness Month , an annual CDC program that highlights the importance of routine vaccination for people of all ages.

UnidosUS Launches ¿Y La Vacuna? Campaign Dedicated to Vaccine Education Among Latino Families

Retrieved on: 
Tuesday, August 15, 2023
Vaccine, Partnership, Contextual advertising, COVID-19, Language, CDC, UnidosUS, COVID-19 vaccine, National Immunization Technical Advisory Group, Network affiliate, City, Digital, Social media, Safety, Health

WASHINGTON, Aug. 15, 2023 /PRNewswire/ -- UnidosUS, the nation's largest Latino civil rights and advocacy organization, is partnering with the CDC to continue the Esperanza Hope for All program aimed at closing the vaccine gap among Latinos to achieve better health outcomes. As part of these efforts, just in time for National Immunization Awareness Month in August, UnidosUS is launching a new creative public education campaign—¿Y La Vacuna? —to build trust among Latinos in the safety and efficacy of COVID-19 boosters, as well as COVID-19 and flu vaccines.

Key Points: 
  • UnidosUS Esperanza Hope for All program, now in its third year, continues to fight misinformation and increase trust within the Latino community via ¿Y La Vacuna?
  • As part of these efforts, just in time for National Immunization Awareness Month in August, UnidosUS is launching a new creative public education campaign—¿Y La Vacuna?
  • —to build trust among Latinos in the safety and efficacy of COVID-19 boosters, as well as COVID-19 and flu vaccines.
  • "We are proud to continue serving our community as a trusted source of information with our new ¿Y La Vacuna?

Pharmacists available for interviews to discuss fall season vaccinations for COVID-19, RSV, and flu

Retrieved on: 
Wednesday, August 2, 2023
CDC, COVID-19, Pharmacist, RSV, National Immunization Technical Advisory Group, Interview, American Pharmacists Association, Vaccination, Respiratory syncytial virus, Vaccine, Pharmaceutical industry

Pharmacists are available to discuss the following:

Key Points: 
  • Pharmacists are available to discuss the following:
    The most current recommendations for the RSV vaccine, including who should get it, and when
    These interviews can be conducted live or recorded for future publication and broadcast.
  • Public health experts are concerned about the possibility that Americans may be vulnerable this fall and winter to a " tripledemic " of the flu, RSV, and COVID-19.
  • Pharmacists are among the leading providers of routine vaccinations across the country.
  • Recent studies have found that pharmacists have administered the majority of COVID-19 vaccinations, with more than 305 million doses of the vaccine delivered by pharmacists through May 2023.

AstriVax, an innovative vaccine platform company, establishes scientific advisory board with world renowned leaders in vaccine development

Retrieved on: 
Friday, March 24, 2023
Vaccine, GSK, ITM, Tick-borne encephalitis, Civil service commission, HIV, Veterinary medicine, CEPI, COVID-19, Infection, University, Ebola, Yellow fever, Global health, Research, Shingles, Doctor of Philosophy, National Immunization Technical Advisory Group, Book, RSV, European Commission, MD, Influenza vaccine, Tropical medicine, UN, Travel medicine, Vertically transmitted infection, Rabies, WHO, Hygiene, Polyclinic, UNAIDS, London School of Hygiene and Tropical Medicine, Malaria, Management, Zoster vaccine, Global Health

Leuven, Belgium, 24 March 2023 – AstriVax has announced that Dr Emmanuel Hanon will chair the company’s scientific advisory board.

Key Points: 
  • Leuven, Belgium, 24 March 2023 – AstriVax has announced that Dr Emmanuel Hanon will chair the company’s scientific advisory board.
  • Renowned infectious disease experts Dr Peter Piot and Dr Patrick Soentjens have been appointed as the first scientific advisors to the AstriVax scientific advisory board that is being composed.
  • With the support of its scientific advisory board, AstriVax will continue to build its innovative plug-and-play vaccine platform to address important unmet needs in global health.
  • Their combined experience covers the full spectrum of infectious diseases, prophylactic and therapeutic vaccine development and global health management.

Graphene for electronics making strides towards ISO standards - spearheaded by MITO and Cardea

Retrieved on: 
Tuesday, December 20, 2022
ANSI, National Physical Laboratory (United Kingdom), Nature, TAG, Language, National Institute of Standards and Technology, SAN, International Organization for Standardization, Working group, Biotechnology, Health, Graphene, Sensation, EPA, IP, TC, ISCB Senior Scientist Award, NIST, FDA, Nanotechnology, Goldsmith, Biosignal, Core Component Technical Specification, Lead, Agriculture, Technical, National Physical Laboratory, American National Standards Institute, Classification, Multimedia, Environmental monitoring, BPU, Doctor of Philosophy, National Immunization Technical Advisory Group, Electronics, Technical standard, ISO, Medical device, Biology, Cardea

"We see a bright future for diagnostic tools based on graphene electronics, but we're not waiting for that future - we're making it happen!

Key Points: 
  • "We see a bright future for diagnostic tools based on graphene electronics, but we're not waiting for that future - we're making it happen!
  • On the graphene Technical Specification team, that expertise came from Dr. Angela Hight Walker, a Senior Scientist at NIST.
  • Dr. Hight Walker states, "Graphene will play a major role in multiple industries; developing documentary standards will certainly hasten the pace.
  • Having US companies like MITO Materials and Cardea spearhead standards discussions indicates a new threshold of maturity for the U.S.-based graphene industry."

At COP15, Investors Announce Nature Action 100 to Tackle Nature Loss and Biodiversity Decline

Retrieved on: 
Sunday, December 11, 2022
Working group, Biodiversity, Nature, BNP Paribas Asset Management, National Immunization Technical Advisory Group, Conference, Private sector, Church Commissioners, Robeco, Biodiversity loss, Caribbean Research and Management of Biodiversity Foundation, Axa Investment Managers, Columbia Threadneedle Investments, Secretariat, Ceres, United Nations Convention, Biology, Party, Climate change, Security (finance), COP15

MONTREAL, Dec. 11, 2022 /PRNewswire/ -- During a main stage session today at the 15th Conference of the Parties to the United Nations Convention on Biological Diversity (COP15), a group of institutional investors announced the formation of Nature Action 100, a new global engagement initiative which focuses on investors driving urgent action on the nature-related risks and dependencies in the companies they own.

Key Points: 
  • Nature Action 100 aims to drive greater corporate ambition and action on tackling nature loss and biodiversity decline, and will complement the United Nations Convention on Biological Diversity's Global Biodiversity Framework by identifying the private sector actions that need to be undertaken to protect and restore nature and seek to catalyze these actions via investor-company engagements.
  • A formal launch of the Nature Action 100 initiative will take place next year.
  • Investors will focus on companies in sectors deemed to be systemically important to the goal of reversing nature and biodiversity loss by 2030.
  • They will work to ensure companies are taking timely and necessary actions to protect and restore nature and ecosystems.

The Caring Foundation of Texas to offer free vaccinations to students in DFW, Houston regions

Retrieved on: 
Monday, August 1, 2022
Fair Park, Health education, Blue Shield, School, HPV, Plano, California Health Care Foundation, National Immunization Technical Advisory Group, Health, Dental care, COVID-19, Multimedia, Vaccine, DFW, PlazAmericas, Immunization, Vaccination, Blue Cross, Grand, Program, Meningitis, Hygiene, Fashion, Communications satellite, Health insurance, Bellaire Boulevard

RICHARDSON, Texas, Aug. 1, 2022 /PRNewswire/ -- Efforts to bridge immunization gaps caused by the COVID-19 pandemic and decreased preventative health visits is top of mind this year as the The Caring Foundation of Texas ramps up free vaccination opportunities across Texas to facilitate back-to-school readiness and facilitate health education during National Immunization Awareness month.

Key Points: 
  • The Caring Foundation will deploy its Care Van Program to Dallas and Houston area schools and community centers to provide the vaccinations.
  • The following Care Van events have been scheduled in Dallas and Houston, but check the Caring Foundation'scalendar for updates as dates and times can change.
  • Since 1997, the Care Vans have provided more than 1.4 million vaccinations to children across Texas.
  • Established in 1991, The Caring Foundation of Texas is a 501(c)3 organization, funded by community contributions, corporate sponsorships, grants and in-kind donations.

Zhongchao Inc. Announces its MDMOOC Platform Launched Disease Prevention and Distribution Quality Management Course

Retrieved on: 
Monday, June 13, 2022
National Center for Immunization and Respiratory Diseases, Vaccination, Coronavirus, Goal, Company, Neoplasm, Evaluation, Medicine in China, National Immunization Technical Advisory Group, Forward-looking statement, WHO, Growth, Cayman Islands, Private Securities Litigation Reform Act, Technology, Review, NASDAQ, SEC, Association, Public health, Efficiency, Degenerative disease, WeChat, Immunization, Course, Committee, Medicine, Vaccine, Pharmaceutical industry, Public relations, PRC

SHANGHAI, June 13, 2022 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patient management service, today announced its MDMOOC platform launched online training course (the "Course") titled "Disease Prevention and Distribution Quality Management," to staffs (the "Staffs") in various departments for diseases control and prevention, in order to improve their skillsets and efficiency in vaccination management as well as diseases control and prevention.

Key Points: 
  • SHANGHAI, June 13, 2022 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patient management service, today announced its MDMOOC platform launched online training course (the "Course") titled "Disease Prevention and Distribution Quality Management," to staffs (the "Staffs") in various departments for diseases control and prevention, in order to improve their skillsets and efficiency in vaccination management as well as diseases control and prevention.
  • The Course was launched in April 2022 and is expected to provide trainings for up to 20,000 people.
  • Participants can access the Course through MDMOOC's website, the Company's WeChat public account, and the Company's WeChat mini program platform.
  • The Company undertakes no obligation to publicly revise these forwardlooking statements to reflect events or circumstances that arise after the date hereof.